Improving clinical trial efficiency by biomarker-guided patient selection

被引：0
|
作者：
Ruud Boessen
Hiddo J Lambers Heerspink
Dick De Zeeuw
Diederick E Grobbee
Rolf HH Groenwold
Kit CB Roes
机构：
[1] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[2] University Medical Center Groningen,Department of Clinical Pharmacology
来源：
Trials | / 15卷
关键词：
Clinical trial designs; Biomarkers; Baseline selection; Active run-in;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system
    Renovanz, Mirjam
    Kurz, Sylvia C.
    Rieger, Johannes
    Walter, Bianca
    Becker, Hannes
    Hille, Hanni
    Bombach, Paula
    Rieger, David
    Grosse, Lucia
    Haeusser, Lara
    Skardelly, Marco
    Merk, Daniel J.
    Paulsen, Frank
    Hoffmann, Elgin
    Gani, Cihan
    Neumann, Manuela
    Beschorner, Rudi
    Riess, Olaf
    Roggia, Cristiana
    Schroeder, Christopher
    Ossowski, Stephan
    Armeanu-Ebinger, Sorin
    Gschwind, Axel
    Biskup, Saskia
    Schulze, Martin
    Fend, Falko
    Singer, Stephan
    Zender, Lars
    Lengerke, Claudia
    Brucker, Sara Yvonne
    Engler, Tobias
    Forschner, Andrea
    Stenzl, Arnulf
    Kohlbacher, Oliver
    Nahnsen, Sven
    Gabernet, Gisela
    Fillinger, Sven
    Bender, Benjamin
    Ernemann, Ulrike
    Oener, Oeznur
    Beha, Janina
    Malek, Holly Sundberg
    Moeller, Yvonne
    Ruhm, Kristina
    Tatagiba, Marcos
    Schittenhelm, Jens
    Bitzer, Michael
    Malek, Nisar
    Zips, Daniel
    Tabatabai, Ghazaleh
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [22] Optimized clinical randomized controlled trials designed for biomarker-guided antibiotics stewardship
    Chen, Wensen
    Zhang, Kai
    Liu, Yun
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (04)
  • [23] GABAPENTIN AS A POTENTIAL BIOMARKER-GUIDED PHARMACOTHERAPY IN ASD
    Cochran, David
    Kennedy, David N.
    Hodge, Steven M.
    Mata, Arline
    Frazier, Jean A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S356 - S356
  • [24] Biomarker-Guided Development of DNA Repair Inhibitors
    Cleary, James M.
    Aguirre, Andrew J.
    Shapiro, Geoffrey I.
    D'Andrea, Alan D.
    MOLECULAR CELL, 2020, 78 (06) : 1070 - 1085
  • [25] Emerging Biomarker-Guided Therapies in Prostate Cancer
    Deluce, Jasna E.
    Cardenas, Luisa
    Lalani, Aly-Khan
    Vareki, Saman Maleki
    Fernandes, Ricardo
    CURRENT ONCOLOGY, 2022, 29 (07) : 5054 - 5076
  • [26] Biomarker-guided management of acute kidney injury
    Kane-Gill, Sandra L.
    Meersch, Melaine
    Bell, Max
    CURRENT OPINION IN CRITICAL CARE, 2020, 26 (06) : 556 - 562
  • [27] Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?
    Albert, Christian
    Haase, Michael
    Albert, Annemarie
    Zapf, Antonia
    Braun-Dullaeus, Ruediger Christian
    Haase-Fielitz, Anja
    ANNALS OF LABORATORY MEDICINE, 2021, 41 (01) : 1 - 15
  • [28] Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
    Antoniou, Miranta
    Jorgensen, Andrea L.
    Kolamunnage-Dona, Ruwanthi
    PLOS ONE, 2016, 11 (02):
  • [29] Potential Clinical Value of Biomarker-Guided Emergency Triage for Thoracic Aortic Dissection
    Qiu, Peng
    Yang, Meng
    Pu, Hongji
    Hou, Jingli
    Chen, Xu
    Wu, Zhaoyu
    Huang, Qun
    Huang, Siyi
    Fu, Yan
    Wen, Zi'ang
    Zhang, Chengxin
    Zha, Binshan
    Yang, Yang
    Xu, Zhijue
    Chen, Fuxiang
    Lu, Xinwu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [30] Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials
    Park, Jay J. H.
    Harari, Ofir
    Dron, Louis
    Mills, Edward J.
    Thorlund, Kristian
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 15
12345